Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 1999 September;43(3) > The Quarterly Journal of Nuclear Medicine 1999 September;43(3):217-23

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

  ENDOCRINOLOGY - I
Diagnostic procedures


The Quarterly Journal of Nuclear Medicine 1999 September;43(3):217-23

Copyright © 2000 EDIZIONI MINERVA MEDICA

lingua: Inglese

Nuclear med­i­cine ­imaging of phe­och­rom­o­cy­toma and neu­ro­blas­toma

Sisson J. C., Shulkin B. L.

From the Divi­sion of ­Nuclear Med­i­cine Depart­ment of ­Internal Med­i­cine Uni­ver­sity of Mich­igan ­Health ­Systems, Ann Arbor, Michigan, USA


FULL TEXT  


Both phe­och­rom­o­cy­tomas and neu­ro­blas­tomas can now be iden­ti­fied and ­located ­with a ­high ­level of accu­racy. Scin­tig­raphy ­with ­MIBG has ­become an indis­pens­able diag­nostic ­method for ­defining the ­extent and loca­tion of ­many if not ­most phe­och­rom­o­cy­tomas. To ­define the ­stage, to doc­u­ment the ­course and to eval­uate the ­response to ther­a­pies in ­patients ­with neu­ro­blas­toma, ­imaging ­with ­MIBG is now essen­tial.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail